April 1, 2008 —
Item Group Appoints Dan Reifsteck CEO of Ximedica
Providence, RI – April 1, 2008 – Item Group has announced the appointment of Dan Reifsteck as CEO of Ximedica, a wholly owned subsidiary which specializes in the design, development and supply of innovative medical devices. As CEO, Reifsteck will be responsible for the continued growth of Ximedica, which provides services to leading medical device companies such as Boston Scientific, Davol and DePuy Mitek.
Reifsteck says, “This is a very exciting time for Ximedica which has invested heavily in expanding the depth and breadth of our engineering, design, regulatory and manufacturing teams. They are now of exceptional caliber and we will continue to build our reputation on this strong foundation,” he said.
With over 10 years in the medical device industry, Reifsteck was recently the Head of Global Services for IT Solutions for Agfa (formally Heartlab). In this role Dan was responsible for establishing strategy, business objectives and key performance indicators for their International Healthcare IT Services Business. Throughout his tenure at Heartlab, Dan held a variety of positions including, VP of Global Cardiology Business, COO, VP of Engineering Operations, and Director of Quality & Regulatory Affairs.
“We are very excited to have someone of Dan’s reputation and experience,” said Stephen Lane, Co-Founder and CEO of Item Group. “As one of the few full service suppliers in the industry, Ximedica is at the forefront of meeting the growing trend among medical device companies to outsource manufacturing,” said Lane.
Visit us at the MD&M East show in NY at booth # 1965.
###
Ximedica, LLC, an Item Group company, is a contract design, development and manufacturing company specializing in capital and disposable medical devices and instruments. Ximedica is ISO 13485:2003 certified by BSI Management Systems for medical device design and manufacturing. Ximedica participates in the entire development process from initial design exploration to supply of finished goods. Its core competencies include mechanical and electronics design as well as firmware and software implementation. In addition, Ximedica, is QSR compliant and FDA registered and offers design control
compliance related documentation tracking, and offshore sourcing of components and subassemblies. Ximedica is headquartered in Providence, Rhode Island with offices in Hong Kong and China. For more information visit www.ximedica.com
